Trial Profile
Phase II trial of X-82 in patients with solid tumors
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 02 Apr 2015
Price :
$35
*
At a glance
- Drugs Vorolanib (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- Sponsors Tyrogenex
- 02 Apr 2015 New trial record